Curiox Biosystems is committed to enabling accurate biological analysis through automation. Next-generation methods and applications--including single-cell 'omics technologies, flow cytometry, immunotherapy, and cell and gene therapy--deserve a next-generation approach to preparing samples for analysis. That’s why Curiox invented Laminar Wash technology, the only sample preparation method that eliminates centrifugation and the problems it introduces. The methodology keeps cells in their native state, improves cell retention and viability, and enhances reproducibility and miniaturization, ultimately leading to reduced costs and workflow standardization.
Location: South Korea, Geumcheon-gu
Employees: 51-200
Total raised: $30M
Founded date: 2008
Investors 1
Date | Name | Website |
- | Muirwoods ... | muirwoodsv... |
Funding Rounds 2
Date | Series | Amount | Investors |
16.03.2022 | Series C | $15M | - |
16.10.2019 | Series B | $15M | - |
Mentions in press and media 4
Date | Title | Description | Source |
16.03.2022 | Curiox Biosystems Closes $15M Series C Funding Round | Curiox Biosystems, Inc., a Woburn, Mass.-based leader in biological sample preparation automation, c... | finsmes.co... |
18.10.2019 | Singapore: Zig Ventures-backed Curiox raises $15m, eyes Kore... | Premium Curiox Biosystems, a bio-instrumentation company backed by Singapore-based venture investmen... | dealstreet... |
18.10.2019 | Daily funding roundup - October 17th, 2019 | Rentgrata has raised $1M; Evervault has raised $3.2M; Versameb has raised $6.5M Rentgrata: Rentgrata... | vator.tv/n... |
16.10.2019 | Curiox Biosystems Secures US$15M in Series B Funding | Curiox Biosystems, a Singapore-based developer of bioinstrumentation solutions used in cell analysis... | finsmes.co... |